Faculty Profile

Jill P. Crandall, M.D.

Professional Interests

Dr. Crandall is Director of the Diabetes Clinical Trials Unit and co-director of the DRTC Clinical Research Facilitation Core. She is an experienced clinical investigator with a joint appointments in the Divisions of Endocrinology and Geriatrics. Dr. Crandall is principal investigator for the Einstein sites of the Diabetes Prevention Program Outcomes Study (DPPOS) and the Epidemiology of Diabetes Interventions and Complications (EDIC) study. She is project leader for Heart Risk in Older Adults with Diabetes (HeartROADS), a component of the Program Project, the Metabolic Syndrome of Aging (N. Barzilai, PI). This study is evaluating the relationship between typical age-related changes in glucose metabolism (post-challenge hyperglycemia) and changes in cardiovascular risk markers, including endothelial function. As director of the Clinical Core for the Program Project, The Role of Genes in Exceptional Longevity (N. Barzilai, PI), she is responsible for recruitment, phenotyping and follow-up of a large cohort of elderly subjects with parental longevity. Dr. Crandall is also active in teaching and is the Course Director for the Endocrine Systems course for 2nd year medical students.

4. The Diabetes Prevention Program Research Group. The Diabetes Prevention Program: Design and methods for a clinical trial in the prevention of Type 2 diabetes mellitus. Diabetes Care 1999; 22:623-34.

Einstein Research Profiles (ERP) is one of the innovative technologies to create collaborative bridges within and across the entire bench-to-bedside-to-population spectrum of research. The ERP website has been developed in partnership with Collexis to give investigators easy access to PubMed publications, coauthor networks, information about NIH grants, and research networks.

Media Coverage

Forbes interviews Dr. Jill Crandall about resveratrol, an extract of red wine, and its potential to boost metabolism in humans.

MSN features Dr. Jill Crandall in an article that dispels some current myths about insulin therapy.